Trial Outcomes & Findings for Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses (NCT NCT05702541)

NCT ID: NCT05702541

Last Updated: 2024-03-26

Results Overview

VA was assessed binocularly (both eyes together) using a letter chart and measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity. No hypothesis testing was pre-specified for this endpoint.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

16 participants

Primary outcome timeframe

Day 2 of each study lens type worn during the corresponding crossover period

Results posted on

2024-03-26

Participant Flow

Participants were recruited from one investigative site located in the United States.

This reporting group includes all enrolled participants (16).

Participant milestones

Participant milestones
Measure
LID223194 MF, Then AOHG MF
Lehfilcon A multifocal contact lenses worn first, followed by lotrafilcon B multifocal contact lenses, as randomized. Each product was worn in both eyes for 2 days in a daily wear modality. CLEAR CARE was used for daily cleaning and disinfection.
AOHG MF, Then LID223194 MF
Lotrafilcon B multifocal contact lenses worn first, followed by lehfilcon A multifocal contact lenses, as randomized. Each product was worn in both eyes for 2 days in a daily wear modality. CLEAR CARE was used for daily cleaning and disinfection.
First Wear Period (Approx 2 Days)
STARTED
8
8
First Wear Period (Approx 2 Days)
COMPLETED
8
8
First Wear Period (Approx 2 Days)
NOT COMPLETED
0
0
Second Wear Period (Approx 2 Days)
STARTED
8
8
Second Wear Period (Approx 2 Days)
COMPLETED
8
8
Second Wear Period (Approx 2 Days)
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
LID223194 MF, Then AOHG MF
n=8 Participants
Lehfilcon A multifocal contact lenses worn first, followed by lotrafilcon B multifocal contact lenses, as randomized. Each product was worn in both eyes for 2 days in a daily wear modality. CLEAR CARE was used for daily cleaning and disinfection.
AOHG MF, Then LID223194 MF
n=8 Participants
Lotrafilcon B multifocal contact lenses worn first, followed by lehfilcon A multifocal contact lenses, as randomized. Each product was worn in both eyes for 2 days in a daily wear modality. CLEAR CARE was used for daily cleaning and disinfection.
Total
n=16 Participants
Total of all reporting groups
Age, Continuous
60.3 years
STANDARD_DEVIATION 3.4 • n=5 Participants
60.4 years
STANDARD_DEVIATION 8.0 • n=7 Participants
60.3 years
STANDARD_DEVIATION 5.9 • n=5 Participants
Sex: Female, Male
Female
2 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants
Sex: Female, Male
Male
6 Participants
n=5 Participants
6 Participants
n=7 Participants
12 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
7 Participants
n=5 Participants
8 Participants
n=7 Participants
15 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Race/Ethnicity, Customized
White
5 Participants
n=5 Participants
7 Participants
n=7 Participants
12 Participants
n=5 Participants
Race/Ethnicity, Customized
Black or African American
3 Participants
n=5 Participants
0 Participants
n=7 Participants
3 Participants
n=5 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Asian
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Other
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Day 2 of each study lens type worn during the corresponding crossover period

Population: This analysis population includes all subjects/eyes exposed to any study lenses evaluated in this study.

VA was assessed binocularly (both eyes together) using a letter chart and measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity. No hypothesis testing was pre-specified for this endpoint.

Outcome measures

Outcome measures
Measure
LID223194 MF
n=16 Participants
Lehfilcon A multifocal contact lenses worn during first wear period or second wear period, as randomized.
AOHG MF
n=16 Participants
Lotrafilcon B multifocal contact lenses worn during first wear period or second wear period, as randomized.
Mean Binocular Visual Acuity (VA) With Study Lenses at 4 Meters (logMAR)
-0.06 logMAR
Standard Deviation 0.10
-0.06 logMAR
Standard Deviation 0.07

Adverse Events

Pretreatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LID223194 MF Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LID223194 MF Nonocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

AOHG MF Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

AOHG MF Nonocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Sr. Clinical Project Lead, Vision Care

Alcon Research, LLC

Phone: 1-888-451-3937

Results disclosure agreements

  • Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
  • Publication restrictions are in place

Restriction type: OTHER